Aromatic Hydrocarbon Receptor Repressor (AHRR) is a biomarker of ambient air pollution exposure and Coronary Artery Disease (CAD)
- 14 December 2023
- journal article
- research article
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 105, 104344
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smokingClinical Epigenetics, 2013
- Polycyclic aromatic hydrocarbon-induced oxidative stress and lipid peroxidation in relation to immunological alterationOccupational and Environmental Medicine, 2010
- Studying associations between urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases in the United StatesScience of The Total Environment, 2010
- Variability of urinary concentrations of polycyclic aromatic hydrocarbon metabolite in general population and comparison of spot, first-morning, and 24-h void samplingJournal of Exposure Science & Environmental Epidemiology, 2009
- Cardiovascular effects of air pollutionClinical Science, 2008
- Air Pollution and Cardiovascular InjuryJACC, 2008
- Repression of Aryl Hydrocarbon Receptor (AHR) Signaling by AHR Repressor: Role of DNA Binding and Competition for AHR Nuclear TranslocatorMolecular Pharmacology, 2008
- A possible mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbonsBiochemical and Biophysical Research Communications, 2005
- Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding propertiesThe FASEB Journal, 2005
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004